A detailed history of High Vista Strategies LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 65,812 shares of TYRA stock, worth $1.02 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
65,812
Previous 24,962 163.65%
Holding current value
$1.02 Million
Previous $238,000 286.55%
% of portfolio
0.28%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$9.59 - $13.99 $391,751 - $571,491
40,850 Added 163.65%
65,812 $920,000
Q2 2025

Aug 14, 2025

BUY
$7.06 - $10.86 $7,208 - $11,088
1,021 Added 4.26%
24,962 $238,000
Q4 2024

Feb 14, 2025

BUY
$13.9 - $28.61 $109,295 - $224,960
7,863 Added 48.91%
23,941 $332,000
Q2 2024

Aug 14, 2024

BUY
$14.45 - $20.22 $232,327 - $325,097
16,078 New
16,078 $257,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $652M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.